Publications:

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma.

Frontiers In Immunology

Wang, Xiaoxuan X; Lu, Yaxiao Y; Liu, Ziyi Z; Zhang, Yidan Y; He, You Y; Sun, Cong C; Li, Lanfang L; Zhai, Qiongli Q; Meng, Bin B; Ren, Xiubao X; Wu, Xudong X; Zhang, Huilai H; Wang, Xianhuo X

Publication Date: 2022

Variant appearance in text: TET2: 176G>A; S59N

PubMed Link: 35874768

Variant Present in the following documents:

• DataSheet_1.xlsx, sheet 2

View BVdb publication page

Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib.

Oncotargets And Therapy

Cheng, Qiansong Q; Wang, Jing J; Lv, Chenglan C; Xu, Jingyan J

Publication Date: 2021

Variant appearance in text: TET2: 176G>A; Ser59Asn

PubMed Link: 34079282

Variant Present in the following documents:

• Main text

View BVdb publication page